Editor's key points † Desflurane is known to protect the diabetic heart against subsequent reperfusion injury. † Using an ex vivo model, mechanisms of desflurane post-conditioning on the diabetic heart were assessed. † Key mechanisms were identified which were associated with cardioprotection. † The authors suggest that post-conditioning may be beneficial in diabetic patients.
phosphorylation of Akt and glycogen synthase kinase-3b (GSK-3b), which are important proteins involved in the prosurvival 'Reperfusion Injury Salvage Kinase' pathway.
Methods
After the approval of the local medical ethics committee and after receiving written informed consent, right atrial appendages were obtained during cannulation for cardiopulmonary bypass from non-diabetic patients and patients with type 2 diabetes, who were undergoing routine coronary artery bypass surgery or aortic valve replacement. All patients received total i.v. anaesthesia with propofol, sufentanil, and pancuronium. Preoperative glycosylated haemoglobin (HbA1c) was measured during the operative period; in all patients (with and without diabetes), continuous infusion of fast-acting insulin (Actrapid H; Novo Nordisk Pharmaceutique, Puteaux, France) was initiated as soon as arterial blood glucose concentration exceeded 180 mg dl 21 . Subsequently, the infusion rate was titrated according to a local protocol (,180 mg dl 21 21 , the rate of infusion was increased by 1 units h 21 . Patients with chronic atrial arrhythmia were excluded from the study. The data for the patient characteristics, preoperative drug treatment, preoperative left ventricular ejection fraction, and HbA1c are reported in Table 1 .
Human atrial trabeculae model of hypoxia/ reoxygenation injury

Experimental conditions
Right atrial trabeculae (one to two per appendage) were dissected and suspended vertically between an isometric force transducer (MLT0202, ADInstruments, Sydney, Australia) and a stationary stainless clip in a 200 ml jacketed reservoir filled with daily prepared modified Tyrode's solution containing Desflurane-induced post-conditioning (mM) 120 NaCl, 3. Trabeculae were equilibrated for 90 min to allow optimal mechanical recovery and performance at the apex of the length-active isometric tension curve. At the end of the stabilization period, the trabeculae were randomized to one of the experimental groups detailed below. Trabeculae obtained from the same appendage were included in different experimental groups. The force of contraction (FoC) was measured continuously, digitized at a sampling frequency of 400 Hz, and stored on a writable compact disc for analysis (MacLab, ADInstruments). At the end of each experiment, the length and weight of the muscles were measured. The cross-sectional area of the muscle was calculated, assuming a cylindrical shape and a density of 1. Trabeculae with a cross-sectional area more than 1.0 mm 2 were excluded.
Accordingly, the preparations included had a FoC normalized per cross-sectional area .5.0 mN mm 22 , and the ratio of resting to total force was ,0.45. The endpoint of the study was the recovery of the FoC at 60 min of reoxygenation (FoC 60 , expressed as a percentage of baseline).
Experimental protocol
At the end of the stabilization period, the trabeculae were randomly assigned (sealed envelopes) to one of the experimental groups. In all groups, hypoxia-reoxygenation was performed by replacing 95% O 2 -5% CO 2 with 95% N 2 -5% CO 2 in the buffer for 30 min, followed by a 60 min oxygenated recovery period.
In the diabetic control group (Diab-Control; n¼10), the trabeculae were treated according to the hypoxia-reoxygenation protocol with no drug treatment ( Fig. 1 ).
In the desflurane treatment groups, desflurane was delivered to the organ bath using a specific calibrated vaporizer. In the Diab-Des+Cal and Diab-Cal groups, calphostin C was administered at 1 mM. In the Diab-Des+5-HD and Diab-5-HD groups, 5-HD was administered at 800 mM. In the Diab-PMA and Diab-Diazoxide groups, PMA was administered at 1 mM and diazoxide was administered at 100 mM, respectively. (B) Western blot experimental protocols. Cal, calphostin C; Des, desflurane; Diab, diabetic; 5-HD, 5-hydroxydecanoate; PMA, phorbol 12-myristate 13-acetate.
The desflurane concentration in the carrier gas phase was measured with a calibrated infrared analyser (Capnomac; Datex, Helsinki, Finland). Desflurane-induced post-conditioning was triggered with 6% desflurane (Diab-Des; n¼6) during the first 5 min of reoxygenation; this concentration corresponds to a one minimum alveolar concentration of desflurane in adult humans at 378C.
The mechanisms involved in desflurane-induced post-conditioning were studied in the presence of 1 mM calphostin C, a PKC inhibitor (Diab-Des+Cal; n¼6), and 800 mM 5-hydroxydecanoate (5-HD), a mitoK ATP channel antagonist (Diab-Des+5-HD; n¼6). Pharmacological agents were administered 5 min before, throughout, and 10 min after desflurane exposure. Desflurane at 6% was chosen because we have previously shown that this is the optimal concentration for in vitro induction of post-conditioning in human myocardium. 9 In the pharmacological control groups, the muscles were exposed to 1 mM calphostin C (Diab-Cal; n¼6) and 800 mM 5-HD (Diab-5-HD; n¼6) 5 min before and during the first 15 min of reoxygenation (Fig. 1) .
In the phorbol 12-myristate 13-acetate (PMA) and diazoxide treatment groups, atrial trabeculae were treated according to the hypoxia -reoxygenation protocol and were exposed during the first 15 min of reoxygenation to 1 mM PMA, a PKC activator (Diab-PMA; n¼6), and 100 mM diazoxide, a mitoK ATP channel opener (Diab-Diazoxide; n¼6) (Fig. 1) .
The concentrations of calphostin C, 5-HD, PMA, and diazoxide used have been validated in previous in vitro studies using human myocardium. 10 11 Chemicals Calphostin C, diazoxide, and 5-HD were purchased from Calbiochem/VWR International (Fontenay sous Bois, France), and PMA was obtained from Sigma Aldrich (Saint Quentin Fallavier, France). Desflurane was purchased from Glaxo Wellcome (Marly-le-Roi, France).
Western blot analysis
The right atrial appendage was pinned in a chamber (5 ml) containing modified Tyrode's solution, oxygenated with 95% O 2 -5% CO 2 and maintained at 34 (0.5)8C. The preparation was stimulated at a frequency of 1 Hz.
In all groups, hypoxia was induced after a 90 min equilibration period by replacing 95% O 2 -5% CO 2 with 95% N 2 -5% CO 2 in the buffer for 30 min, followed by a 5 min oxygenated recovery period (Control, n¼4, and Diab-Control, n¼4) or a 5 min exposure to 6% desflurane (Des, n¼4 and Diab-Des, n¼4) (Fig. 1) .
For the western blot, atrial samples were frozen in liquid nitrogen and stored at 2808C before protein extraction and western blot analysis. Frozen tissue samples were subjected to SDS-polyacrylamide gel electrophoresis as previously described. 10 After protein transfer, polyvinylidene fluoride membranes (Immobilon-P) were probed with antibodies for phospho-Akt (Ser473), total Akt, phospho-GSK-3b (Ser9), and total GSK-3b (1/1000 dilution; Cell Signaling Technology, Ozyme, Saint Quentin Yvelines, France). The western blots of each group were stripped and probed again with an antibody against b-tubulin (Santa Cruz Technology) to ensure equivalent loading. The developed films were scanned, and the band densities were quantified using NIH Image J software (Research Service Branch, National Institutes of Mental Health, Bethesda, MD, USA). The phospho-Akt level (Ser473) was normalized to the total Akt level, and the phospho-GSK-3b level (Ser9) was normalized to the total GSK-3b level.
Glycosylated haemoglobin measurement
Arterial blood samples for HbA1c (n¼66) measurement by high-performance liquid chromatography (ADAMS-A1c HA 81-60, Menarini Diagnostics, Firenze, Italy) were obtained before the cardiopulmonary bypass.
Statistical analysis
The endpoint of the study was the recovery of the FoC at 60 min of reoxygenation (FoC 60 , expressed as a percentage of baseline). The power analysis demonstrated that a group size of n¼5 was necessary to detect a difference of 40% in the FoC [control and inhibitor groups: FoC 60 ¼50 (9)% of baseline, and desflurane (6%) group: FoC 60 ¼90 (9)% of baseline] with a power of 0.8 at an a-level of 0.05. The number of experiments per group was calculated based on a one-way analysis of variance (ANOVA) with four control and inhibitor groups and one 6% desflurane-treated group. Data are expressed as the mean (SD). Baseline values of the primary mechanical parameters, patient age, preoperative left ventricular ejection fraction, and the FoC 60 were compared by univariate ANOVA with the group factor as the independent variable. If the P-value was ,0.05, a Bonferroni post hoc analysis was performed. Within-group data were analysed over time using a two-way ANOVA for repeated measures and the Bonferroni post hoc analysis with group factor and time (baseline; hypoxia for 5, 10, 20, 30 min; and reoxygenation for 5, 10, 20, 30, 40, 50, and 60 min) as the independent variables.
In western blotting, the band densities for the protein of interest were then normalized to that of the band for b-tubulin in the same sample, and values are expressed as the mean (SD). Statistical comparisons were made by the use of the ANOVA for repeated measures and the Bonferroni post hoc analysis. All P-values were two-tailed, and a P-value of ,0.05 was required to reject the null hypothesis. Statistical analysis was performed using Statview 5 software (Deltasoft, Meylan, France).
Results
The patient characteristics, preoperative treatments, left ventricular ejection fraction, and HbA1c levels are shown in Table 1 . Fifty-two human right atrial trabeculae and 16 right atrial appendages were studied. There were no significant differences between the groups in terms of the trabecular length at the apex of the length-active isometric tension Desflurane-induced post-conditioning curve, cross-sectional area, ratio of resting-to-total force ( Table 2 ).
Effects of 5-HD and calphostin C on desflurane-induced post-conditioning (Fig. 2) .
Post-conditioning effects of PMA and diazoxide
When compared with the Diab-Control group, the groups treated with PMA and diazoxide showed enhanced recovery of the FoC 60 [Diab-PMA: 91 (4)% of baseline and Diab-Diazoxide: 87 (9)% of baseline; P,0.0001 vs Diab-Control] (Fig. 2) .
Phosphorylation of Akt and glycogen synthase kinase 3b in the diabetic and non-diabetic human myocardium exposed to desflurane As illustrated in Figure 3 , desflurane (6%) administered in the first 5 min of reoxygenation significantly increased the ratio of phospho-Akt (Ser473) to Akt in the non-diabetic group (+89% in Des vs Control; P,0.0001) and in the diabetic group (+84% in Diab-Des vs Diab-Control; P,0.0001). Similarly, desflurane (6%) administered in the first 5 min of reoxygenation significantly increased the ratio of phosphorylated GSK-3b (Ser9) to GSK-3b in the non-diabetic group (+110% in Des vs Control, P,0.0001) and in the diabetic group (+102% in Diab-Des vs Diab-Control, P,0.0001) (Fig. 3) .
Discussion
The present study showed that the in vitro desflurane-induced post-conditioning of human myocardium obtained from patients with type 2 diabetes involved the activation of PKC, the opening of mitoK ATP channels, and the phosphorylation of Akt and GSK-3b.
Limited data are available on the mechanisms involved in the cardioprotection of diabetic myocardium, and the results of the experimental studies remain contradictory. 12 To our knowledge, only two studies have examined the role of PKC during ischaemia-reperfusion in diabetic rat hearts. 13 14 It has been shown using isolated diabetic rat hearts that 4 week streptozotocin-induced diabetes increases the resistance to ischaemia -reperfusion injury and that this effect was eliminated by chelerythrine, a non-specific PKC inhibitor. 13 Moreover, translocation of PKC-1 from the cytosolic fraction to the mitochondrial fraction was persistent, whereas it was transiently in the non-diabetic heart. 14 The present study shows that inhibition of PKC abolished the desflurane-induced post-conditioning in isolated human myocardium obtained from patients with type 2 diabetes. In isolated non-contractile human diabetic myocardium, Hassouna and colleagues 7 showed that PKC activation by PMA before the prolonged ischaemia provided cardioprotective effects. In the present study, the activation of PKC during the first few minutes of reoxygenation was shown to trigger post-conditioning. Thus, preconditioning and post-conditioning may be effective in the diabetic myocardium and may share a common signalling pathway, including the activation of PKC. 15 However, further studies should be performed to identify the role of the different PKC isoforms.
At the present time, the role and function of mitoK ATP channels in the diabetic myocardium remain unclear. Our results showed that, in the myocardium from patients with type 2 diabetes, desflurane-induced myocardial post-conditioning was abolished in the presence of 5-HD. It has been shown that 5-HD inhibits myocardial post-conditioning in the non-diabetic myocardium; 10 11 however, there were no data for the diabetic myocardium. Although protective signalling pathways are shared by preconditioning and postconditioning in the non-diabetic myocardium, 15 this result must be examined in the diabetic myocardium. Most experimental studies have shown that diazoxide is not able to trigger preconditioning in the diabetic myocardium or during acute hyperglycaemia. 16 -18 The present results
show that diazoxide that is administered at the beginning of reoxygenation significantly increased the recovery of the FoC 60 . Several reasons may explain this discrepancy. First, diazoxide was administered as a preconditioning stimulus 14 -16 in previous studies, whereas in the present study, it was administered as a post-conditioning stimulus. Secondly, in Ghosh and colleagues' study, 16 all patients with type 2 diabetes were treated with K ATP channel antagonists, whereas in our study, only a few patients with type 2 diabetes were treated with K ATP channel antagonists (Table 1) . Thirdly, HbA1c measurements (Table 1) suggested that diabetic patients had well-controlled glycaemia in the present study. Fourthly, the species and experimental model differences may be of importance. Isolated human myocardium obtained from patients with diabetes should definitely not be compared with the experimental diabetes obtained previously using animal models of type 2 diabetes, such as young dogs with diabetes induced by alloxan and streptozotocin 18 and the Zucker obese rat. 17 Additionally, it has been suggested that a higher threshold may be required to activate the cardioprotective signalling pathways in the diabetic myocardium. 9 19 Finally, it has been argued that the effects of diazoxide and 5-HD in inducing and blocking the preconditioning, respectively, may reflect mitochondrial bioenergetic function actions that do not necessarily involve mitoK ATP channels. 20 -22 Western blot experiments showed a significant increase in the phosphorylation of Akt and GSK-3b after a brief exposure to desflurane (6%) during early reoxygenation in the nondiabetic and diabetic myocardium. This result suggests that the Akt/GSK-3b protective signalling pathway can be recruited by desflurane in both the diabetic and non-diabetic myocardium. It has been shown that the inactivation (phosphorylation) of GSK-3b plays a key role in myocardial postconditioning, both ischaemic and pharmacological, through the inhibition of the mitochondrial permeability the inhibition of transition pore opening. 23 -25 In addition, pharmacological inhibition of GSK-3b at the time of reperfusion reduces the myocardial infarct size in streptozotocin-induced diabetic rats. 25 Tsang and colleagues reported that three cycles of ischaemic preconditioning are necessary to reduce the myocardial infarct size in diabetic rats and that the effect was commensurate with significant Akt phosphorylation. They suggested that repeated ischaemic preconditioning stimuli are needed to achieve the threshold for cardioprotection and that a critical level of Akt phosphorylation is necessary to protect the diabetic myocardium. 26 Taken together, these results suggest that the 'Reperfusion Injury Salvage Kinase' signalling pathway can be activated by desflurane-induced post-conditioning in human myocardium from patients with type 2 diabetes. The current findings should be interpreted within the constraints of potential limitations. First, the effects of the anaesthetic drugs; physiological conditions, including other diseases; or medical treatments received by the patients before obtaining the atrial appendages cannot be ruled out. However, in clinical practice, patients for whom cardioprotective strategies may be proposed are likely to have similar conditions, treatments, or both, and it is of interest to examine the effects of cardioprotective strategies under conditions closely resembling clinical situations. Secondly, although our experimental groups were comparable demographically (Table 1) , age has been shown to impair the protective effects of ischaemic post-conditioning in senescent mouse hearts. 27 -29 It is important to note that our study included a control group that was equally affected by these potentially modifying factors. Thirdly, in 12 patients, i.v. insulin has been used to control blood glucose concentration before atrial appendage (two in the Diab-Control, Diab-Des+5-HD, Diab-Cal, Diab-5-HD, Diab-PMA groups; one in Diab-Des and Diab-Diazoxide groups). Insulin has been shown to activate cell survival pathways, including the PI3-kinase/Akt-dependent pathway. 30 Fourthly, the treatments used to equilibrate glycaemia, such as sulfonylureas which increase insulin secretion by blocking the K ATP channel in the pancreatic b-cell membrane, can affect myocardial K ATP channel. 31 We have included a number of patients with type 2 diabetes treated with antagonists of K ATP channels (Table 1 , preoperative treatments). Fifthly, our experiments were performed under moderate hypothermia (348C) to ensure the stability of the trabeculae over time. It has been shown that hypothermia may decrease the sensitivity of mitoK ATP channels. 32 However, during surgical procedures, moderate hypothermia may occur. Then, the specificity of the activators and inhibitors used in the present study should be considered. Diazoxide and 5-HD have also been shown to modify the mitochondrial respiratory chain complex. 20 -22 Finally, we studied isolated contracting human atrial trabeculae but not the myocardial ventricular infarct size. Important functional and structural differences exist between the atrial and ventricular myocardium. However, for ethical reasons, it is not possible to obtain systematic ventricular biopsies from patients undergoing coronary artery bypass graft surgery or aortic valve replacement. Additionally, as described for the myocardial preconditioning, the beneficial effects of post-conditioning have also been described for reperfusion-induced arrhythmias 33 and myocardial conctractility. 34 
Conclusion
Using isolated human myocardium from patients with type 2 diabetes, we showed that the activation of PKC, the opening of mitoK ATP channels and changes in mitochondrial bioenergetic function, the phosphorylation of Akt, and the phosphorylation of GSK-3b were involved in desflurane-induced post-conditioning (Fig. 4) . Moreover, activation of PKC and treatment with diazoxide at the beginning of reoxygenation were cardioprotective in the diabetic myocardium (Fig. 4) . These results raise the possibility that diabetic patients may benefit from pharmacological post-conditioning.
